97 related articles for article (PubMed ID: 10339655)
1. Protein synthesis inhibitor-mediated stability of adenomatous polyposis coli mRNA levels in HCT-116 colon cancer cells.
Jaiswal AS; Narayan S
Int J Oncol; 1999 Jun; 14(6):1045-8. PubMed ID: 10339655
[TBL] [Abstract][Full Text] [Related]
2. Protein synthesis and transcriptional inhibitors control N-methyl-N'-nitro-N-nitrosoguanidine-induced levels of APC mRNA in a p53-dependent manner.
Jaiswal AS; Narayan S
Int J Oncol; 1998 Oct; 13(4):733-40. PubMed ID: 9735403
[TBL] [Abstract][Full Text] [Related]
3. Zinc stabilizes adenomatous polyposis coli (APC) protein levels and induces cell cycle arrest in colon cancer cells.
Jaiswal AS; Narayan S
J Cell Biochem; 2004 Oct; 93(2):345-57. PubMed ID: 15368361
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
5. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
Wakita K; Tetsu O; McCormick F
Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
[TBL] [Abstract][Full Text] [Related]
6. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
7. A correlation of APC and c-myc mRNA levels in lung cancer cell lines.
Jaiswal AS; Kennedy CH; Narayan S
Oncol Rep; 1999; 6(6):1253-6. PubMed ID: 10523691
[TBL] [Abstract][Full Text] [Related]
8. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
[TBL] [Abstract][Full Text] [Related]
9. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
Green DW; Roh H; Pippin JA; Drebin JA
J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
[TBL] [Abstract][Full Text] [Related]
10. Reduced levels of the adenomatous polyposis coli (APC) protein are associated with ceramide-induced apoptosis of colon cancer cells.
Jaiswal AS; Narayan S
J Cancer Res Clin Oncol; 2004 Dec; 130(12):695-703. PubMed ID: 15340841
[TBL] [Abstract][Full Text] [Related]
11. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization.
Kobayashi N; Takada Y; Hachiya M; Ando K; Nakajima N; Akashi M
Cytokine; 2000 Dec; 12(12):1745-54. PubMed ID: 11097743
[TBL] [Abstract][Full Text] [Related]
12. N-methyl-N'-nitro-N-nitrosoguanidine-induced senescence-like growth arrest in colon cancer cells is associated with loss of adenomatous polyposis coli protein, microtubule organization, and telomeric DNA.
Jaiswal AS; Multani AS; Pathak S; Narayan S
Mol Cancer; 2004 Jan; 3():3. PubMed ID: 14728717
[TBL] [Abstract][Full Text] [Related]
13. Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells.
Huang X; Guo B
Cancer Res; 2006 Sep; 66(18):9245-51. PubMed ID: 16982769
[TBL] [Abstract][Full Text] [Related]
14. 3,3'-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin.
Bhatnagar N; Li X; Chen Y; Zhou X; Garrett SH; Guo B
Cancer Prev Res (Phila); 2009 Jun; 2(6):581-9. PubMed ID: 19470789
[TBL] [Abstract][Full Text] [Related]
15. Cytoskeleton out of the cupboard: colon cancer and cytoskeletal changes induced by loss of APC.
Näthke I
Nat Rev Cancer; 2006 Dec; 6(12):967-74. PubMed ID: 17093505
[TBL] [Abstract][Full Text] [Related]
16. Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent.
Chen T; Turner J; McCarthy S; Scaltriti M; Bettuzzi S; Yeatman TJ
Cancer Res; 2004 Oct; 64(20):7412-9. PubMed ID: 15492264
[TBL] [Abstract][Full Text] [Related]
17. Reliable and sensitive detection of premature termination mutations using a protein truncation test designed to overcome problems of nonsense-mediated mRNA instability.
Bateman JF; Freddi S; Lamandé SR; Byers P; Nasioulas S; Douglas J; Otway R; Kohonen-Corish M; Edkins E; Forrest S
Hum Mutat; 1999; 13(4):311-7. PubMed ID: 10220145
[TBL] [Abstract][Full Text] [Related]
18. Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study.
Schnitzler M; Dwight T; Robinson BG
Gut; 1996 May; 38(5):707-13. PubMed ID: 8707116
[TBL] [Abstract][Full Text] [Related]
19. p53-dependent transcriptional regulation of the APC promoter in colon cancer cells treated with DNA alkylating agents.
Jaiswal AS; Narayan S
J Biol Chem; 2001 May; 276(21):18193-9. PubMed ID: 11279192
[TBL] [Abstract][Full Text] [Related]
20. Impact of adenomatous polyposis coli (APC) tumor supressor gene in human colon cancer cell lines on cell cycle arrest by apigenin.
Chung CS; Jiang Y; Cheng D; Birt DF
Mol Carcinog; 2007 Sep; 46(9):773-82. PubMed ID: 17620292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
